EFFECT OF ZEIN ON CIPROFLOXACIN FLOATING TABLETS
Keywords:Ciprofloxacin Hydrochloride; Gastroretentive Drug Delivery System; Higuchi model; Floating time
Objective: This work was aimed to formulate and evaluate the effect of zein on Ciprofloxacin HCl floating tablets. According to previous studies, it was set up to be useful against bacteria i.e. Helicobacter pylori which leads to peptic ulcers. Thus, it is quite necessary to enhance the Gastric Retention Time for similar medicines.
Methods: 12 different floating tablets of Ciprofloxacin HCl were formulated with wet granulation method with a rise in the concentration of zein. Further, all different formulations prepared were evaluated for different parameters i.e. pre-compression considerations along with post-compression factors like weight variation, content uniformity, thickness, visual assessment, hardness, friability, buoyancy studies i.e. total floating time as well as floating lag time, swelling index, dissolution and drug release kinetics.
Results: The F6 formulation was considered to be among finest formulation with appropriate hardness. It was found that with the increasing concentration of zein the hardness of tablets was also increased. It showed TFT of more the 7 h, FLT of 310 sec, a swelling index time of 99.5 % in 4 hr while drug release kinetics was found to follow Higuchi Model.
Conclusion: Overall it was also found that HPMCK100M is more effective as compared to HPMC-K15M and Zein has a major role in increasing the hardness of tablets. In the future, the investigation will be continued with the following studies: An in-vivo study and a long-term stability study.
Kumar A, Srivastava R. In Vitro In Vivo Studies On Floating Microspheres For Gastroretentive Drug Delivery System: A Review. Asian J. Pharm. Clin. Res. 2021 Jan 5:13-26.
Rajora A, Nagpal K. A Critical Review on Floating Tablets as a Tool for Achieving Better Gastric Retention. Crit Rev Ther Drug Carrier Syst. 2022;39(1):65-103.
Thulluru A, Basha SS, Rao CB, Kumar CS, Mahammed N, Kumar KS. Optimization of HPMC K100M and sodium alginate ratio in Metronidazole Floating Tablets for the Effective Eradication of Helicobacter pylori. Asian j. pharm. technol .2019;9(3):195-203.
Siahaan RD, Bangun H, Sumaiyah S. In vitro and in vivo evaluation of floating gastroretentive drug delivery system of cimetidine using hard alginate capsules. Asian J. Pharm. Clin. Res. 2018 Jun 7:162-8.
Roy A, Arees R, Blr M. Formulation development of oral fast-dissolving films of rupatadine fumarate. Asian J Pharm Clin Res. 2020;13(11):67-72.
Jhain SK, Jhain NK, Agarwal GP. Gastro retentive floating drug delivery: An overview. Drug Deliv Technol. 2005;5:21–31.
Banker GS, Anderson NR. Tablets In: Lachman L, Lieberman A, Kanig JL. The theory and practice of industrial pharmacy. Third Edition, Bombay: Varghese publishing house. 1991;317.
Vyas J, Mehta J, Pal N, Daxini K. Development and optimization of floating tablets containing rebamipide. Res. J. Pharm. Dos. Forms technol. . 2020;12(1):7-12.
Carr RL. Evaluation of flow properties of solid. Chem. Eng. 1965;3:163-168.
Manoj G, Rajesh P, Kapil KP, Mehta SC. Floating drug delivery system. J Current Pharma Res. 2011;05:07-18.
Dodou D, Breedveld P, Wieringa PA. Mucoadhesives in the gastrointestinal tract: revisiting the literature for novel applications. Eur J Pharm Biopharm. 2005;60:01-16.
Brahmankar DM, Jaiswal SB. Biopharmaceutics and Pharmacokinetics a treatise. Vallabh prakashan New Delhi. 1995;64-70.
Mayavanshi AV, Gajjar SS. Floating drug delivery systems to increase gastric retention of drugs: A review. Res J Pharma Tech. 2008;1:345-348.
Tadros MI. Controlled-release effervescent floating matrix tablets of Ciprofloxacin hydrochloride: Development, optimization and in vitro-in vivo evaluation in healthy human volunteers. Eur J Pharm Biopharm. 2010;74:332-339.
Pharmacopoeia I. Government of India Ministry of Health & Family Welfare, Published By the Indian Pharmacopoeia Commission. Volume 1st. 2007;477(478):177-83.
Debjit Bhowmik, Chiranjib B, Krishnakanth P, Chandira RM. Fast dissolving tablet an overview. J. Chem. Pharm. Res. . 2009;1:163-177.
Amrutha JV. Pre and post compression studies of tablets, Inorganic chemistry an Indian journal. 2016;3:1-10.
Reddy VS. Formulation and Evaluation of Floating Tablets of Ciprofloxacin Hydrochloride. Asian J Pharm : Free full text articles from Asian J Pharm. 2018;12.
Pharmaceutical Technology Editors, Achieving Zero-Order Release Kinetics Using Multi-Step Diffusion-Based Drug Delivery. Pharm. Technol. 5:2014.
Patel H, Panchal DR, Patel U, Brahmbhatt T. Matrix type drug delivery system: A review. J Pharm Sci Biosci Res. 2011;1:143-151.
Gaikwad VD, Yadav VD, Gaikwad MD. Novel sustained release and swellable gastroretentive dosage form for Ciprofloxacin hydrochloride. Int J Pharm Investig. 2014;2:88.
Deshpande AA, Rhodes CT, Shah NH. Controlled release drug delivery systems for prolonged gastric residence: An overview. Drug Dev Ind Pharm. 1996;22:531–539.
Arza RA, Gonugunta CS, Veerareddy PR. Formulation and evaluation of swellable and floating gastroretentive Ciprofloxacin hydrochloride tablets. Aaps Pharmscitech. 2009;1:220-226.
Prajapati ST, Patel LD, Patel DM. Gastric floating matrix tablets: design and optimization using combination of polymers. Acta Pharm. 2008;58:221–229.
Sauzet C, Claeys-Bruno M, Nicolas M, Kister J, Piccerelle P, Prinderre P. An innovative floating gastro retentive dosage system: formulation and in vitro evaluation. Int. J. Pharm. 2009;378(1–2):23–29.
Garg R, Gupta GD. Progress in controlled gastroretentive delivery systems. Trop. J. Pharm. Res. 2008;7(3):1055–1066.
Xiaoqiang X, Minjie S, Feng Z, Yiqiao H. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers. Int. J. Pharm. 2006;310:139–145.
Deshpande AA, Shah NH, Rhodes CT, Malick W. Development of a novel controlled release system for gastric retention, Pharm. Res. 1997;14:815–819.
Chavanpatil MD, Jain P, Chaudhari S, Shear R, Vavia R.R. Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin. Int. J. Pharm. 2006;316(1–2):86–92.
Hwang SJ, Park H, Park K. Gastric retentive drug-delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 1998;15(3):243–284.
Patel N, Nagesh C, Chandrashekhar S, Jinal P, Devdatt J. Floating drug delivery system: An innovative acceptable approach in gastroretentive drug delivery. Res. j. pharm. dos. forms technol. 2012;4(2):93-103.
Seth PR, Tossounian J. The hydrodynamically balanced system, a novel drug delivery system for oral use. Drug Dev. Ind. Pharm. 1984;10:313–339.
Hondadakatti R, Iliger SR, Lagali M. Formulation and Evaluation of Floating Drug Delivery System of Antidiabetic Drug. Res. j. pharm. dos. forms technol. 2021 Apr 1;13(2):100-6.
Harrigan RM. Drug Delivery Device for Preventing Contact of Undissolved Drug with the Stomach Lining. US Patent 4055178. 1977 October 25.
Whitehead L, Fell JT, Collett JH. Development of a gastroretentive dosage form. Eur. J. Pharm. Sci. 1996;4:S182.
Kawashima Y, Niwa T, Takeuchi H, Hino T, Itoh Y. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J. Pharm. Sci. 1992;81:135–140.
Chen J, Blevins WE, Park H, Park K. Gastric retention properties of superporous hydrogel composites. J. Control. Release. 2000;64(1-3):39–51.
Gröning R, Berntgen M, Georgarakis M. Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extracoporal magnets to control gastrointestinal transit. Eur. J. Pharm. Biopharm. 1998’46:285–291.
Singh BM, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J. Control. Rel. 2000;63:235– 259.
Lippincott Williams & Wilkins, Philadelphia. 21st ed. Remington: The Science and Practice of Pharmacy. 2005;(electronic version).
Jeong YI, Na HS, Seo DH, Kim DG, Lee HC, Jang MK, Na SK, Roh SH, Kim SI, Nah JW. Ciprofloxacin-encapsulated poly (DL-lactide-co-glycolide) nanoparticles and its antibacterial activity. Int. J. Pharm. 2008;352(1-2):317–323.
Jeong YI, Na HS, Nah JW, Lee HC. Preparation of Ciprofloxacin-encapsulated poly (DL-lactide-co-glycolide) microspheres and its antibacterial activity. J. Pharm. Sci. 2009;98(10):3659–3665.
Hajare AA, Patil VA. Formulation and characterization of metformin hydrochloride floating tablets. Asian J. Pharm. Res.2012;2(3):111-117.
Arza RA, Gonugunta CS, Veerareddy PR. Formulation and evaluation of swellable and floating gastroretentive Ciprofloxacin hydrochloride tablets. AAPS Pharm Sci Tech. 2009;10(1):220–226.
Salve PS. Development and in vitro evaluation of gas generating floating tablets of metformin hydrochloride. Asian j. res. pharm. sci. 2011;1(4):105-112.
Varshosaz J, Tavakoli N, Roozbahani F. Formulation and in vitro characterization of Ciprofloxacin floating and bioadhesive extended-release tablets. Drug Deliv. 2006;13(4):277–285.
Srinatha A, Pandit JK. Multi-unit floating alginate system: effect of additives on Ciprofloxacin release. Drug Deliv. 2008;15(7):471–476.
Raza A, Hayat U, Wang HJ, Wang JY. Preparation and evaluation of captopril loaded gastro-retentive zein based porous floating tablets. Int. J. Pharm. 2020;15;579:119185.
Georget DM, Barker SA, Belton PS. A study on maize proteins as a potential new tablet excipient. Eur J Pharm Biopharm. 2008 Jun;69(2):718-26.
Wang GW, Yang H, Wu WF, Zhang P, Wang JY. Design and optimization of a biodegradable porous zein conduit using microtubes as a guide for rat sciatic nerve defect repair. Biomaterials. 2017 Jul;131:145-159.
Kim S, Hwang KM, Park YS, Nguyen TT, Park ES. Preparation and evaluation of non-effervescent gastroretentive tablets containing pregabalin for once-daily administration and dose proportional pharmacokinetics. Int J Pharm. 2018 Oct 25;550(1-2):160-169.
Guo HX, Shi YP. A novel zein-based dry coating tablet design for zero-order release. Int J Pharm. 2009 Mar 31;370(1-2):81-6.
Nguyen MNU, Tran PHL, Tran TTD. A single-layer film coating for colon-targeted oral delivery. Int J Pharm. 2019 Mar 25;559:402-409..
Wang, H., Zhang, X., Zhu, W., Jiang, Y., Zhang, Z., 2018. Self-assembly of zein-based microcarrier system for colon-targeted oral drug delivery. Ind. Eng. Chem. Res. 2018 Sep 5;57(38):12689-99.
Berardi, A., Bisharat, L., Cespi, M., Basheti, I.A., Bonacucina, G., Pavoni, L., AlKhatib, H.S., 2017. Controlled release properties of zein powder filled into hard gelatin capsules. Powder Technol. 2017 Oct 1;320:703-13.
Raza A, Shen N, Li J, Chen Y, Wang JY. Formulation of zein based compression coated floating tablets for enhanced gastric retention and tunable drug release. Eur J Pharm Sci. 2019 Apr 30;132:163-173.
Gong S, Wang H, Sun Q, Xue ST, Wang JY. Mechanical properties and in vitro biocompatibility of porous zein scaffolds. Biomaterials. 2006 Jul;27(20):3793-9.
Hwang KM, Cho CH, Tung NT, Kim JY, Rhee YS, Park ES. Release kinetics of highly porous floating tablets containing cilostazol. Eur J Pharm Biopharm. 2017 Jun;115:39-51.
Thapa P, Jeong SH. Effects of Formulation and Process Variables on Gastroretentive Floating Tablets with A High-Dose Soluble Drug and Experimental Design Approach. Pharmaceutics. 2018 Sep 17;10(3):161.
How to Cite
Copyright (c) 2022 ANSHIKA SINGH, ANJALI RAJORA, RUPA MAZUMDER, SWARUPANJALI PADHI
This work is licensed under a Creative Commons Attribution 4.0 International License.